HUP9900492A3 - 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them - Google Patents

3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them

Info

Publication number
HUP9900492A3
HUP9900492A3 HU9900492A HUP9900492A HUP9900492A3 HU P9900492 A3 HUP9900492 A3 HU P9900492A3 HU 9900492 A HU9900492 A HU 9900492A HU P9900492 A HUP9900492 A HU P9900492A HU P9900492 A3 HUP9900492 A3 HU P9900492A3
Authority
HU
Hungary
Prior art keywords
contg
ketal
pharmaceuticals
enol ether
macrolide antibiotics
Prior art date
Application number
HU9900492A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU9900492D0 publication Critical patent/HU9900492D0/hu
Publication of HUP9900492A2 publication Critical patent/HUP9900492A2/hu
Publication of HUP9900492A3 publication Critical patent/HUP9900492A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU9900492A 1998-03-03 1999-03-02 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them HUP9900492A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (3)

Publication Number Publication Date
HU9900492D0 HU9900492D0 (en) 1999-04-28
HUP9900492A2 HUP9900492A2 (hu) 1999-09-28
HUP9900492A3 true HUP9900492A3 (en) 2001-08-28

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900492A HUP9900492A3 (en) 1998-03-03 1999-03-02 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them

Country Status (17)

Country Link
US (1) US6043226A (hu)
EP (1) EP0941998B1 (hu)
JP (1) JP3666788B2 (hu)
CN (1) CN1244532A (hu)
AR (1) AR016715A1 (hu)
AT (1) ATE275151T1 (hu)
AU (1) AU741435B2 (hu)
BR (1) BR9900856A (hu)
CA (1) CA2263203C (hu)
DE (1) DE69919769T2 (hu)
DK (1) DK0941998T3 (hu)
ES (1) ES2226282T3 (hu)
HU (1) HUP9900492A3 (hu)
NO (1) NO312366B1 (hu)
NZ (1) NZ334442A (hu)
PT (1) PT941998E (hu)
ZA (1) ZA991664B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
CA2349338C (en) * 1998-11-03 2005-12-06 Pfizer Products Inc. Novel macrolide antibiotics
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
ES2272273T3 (es) 1999-04-16 2007-05-01 Kosan Biosciences, Inc. Agentes antiinfecciosos macrolidos.
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) * 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
CA2428158C (en) * 2000-11-07 2010-06-29 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
EP1836211B1 (en) * 2004-12-21 2010-03-03 Pfizer Products Inc. Macrolides
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US20090118506A1 (en) * 2007-09-17 2009-05-07 In Jong Kim 6,11-bridged biaryl macrolides
CA3079368A1 (en) * 2017-04-20 2018-10-25 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193116A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193111A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
EP3612544B1 (en) 2017-04-20 2022-11-23 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
EP3612177A4 (en) 2017-04-21 2021-01-13 Lunella Biotech, Inc. TARGETING HYPOXIC CARCINOUS STEM CELLS (SCC) USING DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
CA3063450A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
KR102646172B1 (ko) 2017-06-26 2024-03-13 루넬라 바이오테크 인코포레이티드 미토케토신: 암 세포에서 케톤 대사를 표적화하는 미토콘드리아-기반의 치료제
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (de) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
CA2154550A1 (en) * 1993-01-26 1994-08-04 Yoko Misawa 5-o-desosaminylerythronolide derivatives
AU2340797A (en) * 1996-05-07 1997-11-26 Abbott Laboratories 6-o-substituted erythromycins and method for making them

Also Published As

Publication number Publication date
EP0941998B1 (en) 2004-09-01
NO991012D0 (no) 1999-03-02
CA2263203A1 (en) 1999-09-03
DE69919769T2 (de) 2005-01-27
NO312366B1 (no) 2002-04-29
HUP9900492A2 (hu) 1999-09-28
ZA991664B (en) 2000-10-12
JPH11315093A (ja) 1999-11-16
HU9900492D0 (en) 1999-04-28
JP3666788B2 (ja) 2005-06-29
CN1244532A (zh) 2000-02-16
NO991012L (no) 1999-09-06
DE69919769D1 (de) 2004-10-07
BR9900856A (pt) 2000-04-25
AU1856299A (en) 1999-09-16
DK0941998T3 (da) 2004-09-20
ES2226282T3 (es) 2005-03-16
ATE275151T1 (de) 2004-09-15
CA2263203C (en) 2002-09-03
US6043226A (en) 2000-03-28
PT941998E (pt) 2004-12-31
EP0941998A2 (en) 1999-09-15
AU741435B2 (en) 2001-11-29
AR016715A1 (es) 2001-07-25
NZ334442A (en) 2000-03-27
EP0941998A3 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
HUP9900492A3 (en) 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them
ZA977474B (en) 6-O-substituted ketolides having antibacterial activity.
ZA9811939B (en) Novel macrolides.
ZA972685B (en) Medicaments.
ZA965019B (en) Isothermal PCR.
ZA972041B (en) Pesticide.
ZA973630B (en) Pesticide.
ZA985018B (en) 9-oxime erythromycin derivatives.
ZA200103289B (en) Novel macrolide antibiotics.
ZA9811940B (en) Novel erythromycin derivatives.
ZA994999B (en) Glazing support systems.
ZA965418B (en) Quick-fermented feed, its preparation and uses.
ZA971272B (en) Gene expression.
HUP9802663A3 (en) Carbohydrate derivatives and pharmaceutical compns. contg. them
ZA975742B (en) Modified oligonucleotides.
ZA959630B (en) Diaminocyclobutene-3, 4-diones.
ZA9711461B (en) Lipophilic oligosaccharide antibiotic compositions.
ZA973957B (en) Pesticide.
ZA976608B (en) Adjustable length conveyor system.
ZA978086B (en) New pyranoside derivatives.
ZA963787B (en) Antibiotics.
GB2316686B (en) Sliding member.
ZA966602B (en) Extrudable microporous insulation.
ZA967545B (en) Pharmaceuticals.
ZA983048B (en) Pinhole-resistant extrusion compositions, method and article.